Clinical Phytoscience

International Journal of Phytomedicine and Phytotherapy

Table 2 Percentage liver, kidney and spleen coefficient in rats administered Mystomate4® at different doses for 3 months and control administered the vehicle

From: Acute and sub-chronic toxicity assessment and evaluation of the gastro-protective activity of polyherbal formulation “Mystomate4®^” against gastric ulcer in experimental laboratory animal

Group	CN	HM-5 mg/kg	HF-5 mg/kg	LM- 2.5 mg/kg	LF-2.5 mg/kg
Liver (%)	1.3409 ± 0.0075	1.3497 ± 0.0075	1.3507 ± 0.0073	1.3401 ± 0.0074	1.3576 ± 0.0074
Kidney (%)	0.7963 ± 0.0071	0.8006 ± 0.0076	0.7834 ± 0.0072	0.7891 ± 0.0070	0.8038 ± 0.0069
Spleen (%)	0.1946 ± 0.0040	0.2060 ± 0.0089	0.2019 ± 0.0071	0.2007 ± 0.0081	0.2015 ± 0.0081

CN Control, HM 5 g/kg male, HF 5 g/kg female, LM 2.5 g/kg male and LF = 2.5 g/kg female; n = 8 rats per group
Statistical comparison was determined by one way ANOVA followed by Tukey’s multiple comparison tests. *P ≤ 0.05, statistically significant compared to control

Back to article page